MMR: CanVIG-UK Gene-Specific Guidance
CanVIG-UK review of MMR genes, 07/10/2025 (MLH1/MSH2/MSH6/PMS2): Consensus to use relevant recommendations from the ClinGen InSiGHT Hereditary Colorectal Cancer/Polyposis Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for MLH1, MSH2, MSH6, and PMS2 Version 1.0.0 (available at: https://clinicalgenome.org/affiliation/50099).Additional points of specification are given below where applicable. Please defer to the respective gene VCEP guidelines for evidence combination rules
Institutions
- Belfast Health and Social Care Trust (GB)
- Cardiff and Vale University Health Board (GB)
- North Bristol NHS Trust (GB)
- Royal Marsden NHS Foundation Trust (GB)
- Nottingham University Hospitals NHS Trust (GB)
- University of Ulster (GB)
- Institute of Cancer Research (GB)
- University of Exeter (GB)
- Leeds Teaching Hospitals NHS Trust (GB)
- Royal Devon & Exeter NHS Foundation Trust (GB)
- Western General Hospital (GB)
- NHS Greater Glasgow and Clyde (GB)
- Great Ormond Street Hospital for Children NHS Foundation Trust (GB)
- St George’s University Hospitals NHS Foundation Trust (GB)
- Southmead Hospital (GB)
- University Hospital Southampton NHS Foundation Trust (GB)
- University of Manchester (GB)
- Children's Health Ireland at Crumlin (IE)
- Sheffield Children's NHS Foundation Trust (GB)
- Royal Victoria Hospital (GB)
- Genomics England (GB)
- Birmingham Women’s and Children’s NHS Foundation Trust (GB)
- Queen Elizabeth University Hospital (GB)
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-02-04
- DOI
- https://doi.org/10.5281/zenodo.15021539
- Primary Topic
- Genomics and Rare Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00